Love the view?
Make it your next adventure.
Explore our travel guides. Share your stories, tips and questions on Reddit.
Explore our travel guides. Share your stories, tips and questions on Reddit.

Biotech catalyst, news and analysis PDUFA tracker

Biotech catalyst, news and analysis PDUFA tracker

Compare Bitcoin holdings with shares, collateral, lending and debt. CleanSpark, HIVE, MARA and Riot show why mining output and shareholder exposure diverge.

Aeroplan’s minority deal and Air Canada’s buyback meet the cash economics of AAdvantage, SkyMiles and MileagePlus. Four airlines, four different ownership claims.

Takeda’s orexin approval changes narcolepsy. Compare Alkermes, Axsome and Jazz through clinical evidence, existing patients, launch timing and business exposure.

CrowdStrike, Castellum, Palo Alto and Zscaler: recurring revenue, funded contracts, acquisition effects and cash conversion across four security stocks.

C3.ai, Salesforce, Microsoft and SoundHound: paid adoption, revenue quality, margins, cash and LivePerson integration in a four-stock AI agents analysis.

A reactor test, an approved design, a fuel contract and commercial electricity are different milestones. A detailed comparison of Oklo, NuScale, Centrus and BWXT follows the current primary evidence, financial obligations, fuel chain and remaining steps between plans and cash-generating operations.

A launch, an operational satellite, a paid service and a cash receipt are different milestones. This detailed comparison follows Rocket Lab, AST SpaceMobile, Intuitive Machines and Redwire through mission evidence, current filings, changed business perimeters, revenue recognition and financing.

A defense selection, a contract ceiling and a funded production order describe different commercial events. This detailed comparison follows Ondas, Red Cat, AeroVironment and Kratos through actual awards, accounting recognition, factory investment, acquisition financing and cash collection.

A geopolitical agreement does not turn a deposit into a qualified magnet. This detailed comparison follows Critical Metals, MP Materials, USA Rare Earth and Energy Fuels from their actual products through processing, customer acceptance and financing, separating completed milestones from future targets.

AI contracts can reach extraordinary sizes while the infrastructure behind them still needs funding. A detailed comparison of CoreWeave, Nebius, IREN and Oracle follows the money from customer commitments through delivery, debt service and the residual available to shareholders.

Audio, display and VR glasses are different businesses. A detailed guide to Meta Connect, Qualcomm's silicon, Google's Android XR and Apple's ecosystem explains what is available, what is still planned and where economic evidence remains missing.

IonQ's planned NVIDIA research-center installation makes hybrid quantum computing tangible. A source-led comparison explains what it means for four companies, which milestones remain ahead and how to separate a working application from a compelling announcement.

From demonstrations to paying customers: how to read PhotonLink, new lasers and AI optics orders without confusing technological promise with commercial results.

The next frontier in obesity treatment also concerns what happens after weight loss. Viking’s September 22 results sharpen the question: how much of the benefit can be preserved, for how long, and with what burden of treatment and side effects?

After the US-Denmark security deal over Greenland, four US-listed names repriced. What Critical Metals, Greenland Mines, Greenland Energy and Twin Vee PowerCats actually own, from their SEC filings.

The scarce resource increasingly deciding how much AI capacity can actually be deployed is electricity. GPUs, networking and models still matter, but the new economic question is how efficiently operators can turn secured megawatts into useful, billable compute. NVIDIA’s DSX platform and the newly launched AI Energy Management Alliance are attempts to make power itself programmable — inside the data center and, potentially, at the grid interface.

From August’s DEA closing briefs to September’s developments: the U.S. medical framework survives a stay request, Congress delays part of the hemp restrictions, Germany raises new questions and Aurora battles Curaleaf. Meanwhile, company accounts are telling increasingly different stories.

Biotech Radar: CNTB asthma data, BIVI Long COVID findings, CRBP obesity results and ARMP FDA designation, plus financing, diagnostics and medtech updates.

How $ONDS, $RCAT, $DPRO and $AVAV are turning defense autonomy into an industry: orders, manufacturing, cash, dilution and the next execution tests.

Bloom Energy, FuelCell and Plug Power: the rally, sector outlook, financials, contracts, liquidity and catalysts, with all three Stock Hubs.